Effect of β-cryptoxanthin (β-Cx), Plant Sterols and Galactooligosaccharides on Systemic and Gastrointestinal Markers
Systemic and Intestinal Therapeutic Target Bioactivity of a Functional Beverage Containing β-cryptoxanthin (β-Cx), Plant Sterols (PS) and Galactooligosaccharides (GOS): in Vivo and in Vitro Studies.
Sponsor: Fundación para la Investigación Biomédica, Hospital Universitario Puerta de Hierro
This NA trial investigates Hypercholesterolemia and Osteoporosis and is currently ongoing. Fundación para la Investigación Biomédica, Hospital Universitario Puerta de Hierro leads this study, which shows 7 recorded versions since 2017 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Unknown NA
-
Jul 2024 — Sep 2024 [monthly]
Unknown NA
Status: Unknown Status → Unknown
-
Oct 2021 — Jul 2024 [monthly]
Unknown Status NA
Status: Active Not Recruiting → Unknown Status
-
Jan 2021 — Oct 2021 [monthly]
Active Not Recruiting NA
-
Jun 2019 — Jan 2021 [monthly]
Active Not Recruiting NA
▶ Show 2 earlier versions
-
Jun 2018 — Jun 2019 [monthly]
Active Not Recruiting NA
-
Apr 2018 — Jun 2018 [monthly]
Active Not Recruiting NA
First recorded
Jan 2017
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Fundación para la Investigación Biomédica, Hospital Universitario Puerta de Hierro
- Global Technology centro, Hero Group
- Nutrition and Food Science Area, Faculty of Pharmacy, University of Valencia
- Puerta de Hierro University Hospital
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
No location information available.